Nomic is a life sciences company dedicated to making biology easier to measure through advanced protein profiling technologies. Their primary innovation, the nELISA platform, incorporates DNA nanotechnology, high-dimensional flow cytometry, laboratory automation, and machine learning to achieve unprecedented throughput in proteomic assays. Since its inception from McGill University, Nomic has partnered with numerous leading drug discovery groups and pharmaceutical companies, enabling the profiling of millions of proteins from vast datasets. The organization fosters a collaborative and diverse team of engineers and scientists who employ a first-principles approach to problem-solving, continuously leveraging the latest scientific advancements to drive innovation and improve biological measurement. With a state-of-the-art facility in Montreal, Nomic remains focused on transforming the landscape of proteomics while striving to contribute to significant advancements in disease detection and treatment.